Psyence adds intraday share sales to White Lion deal
Psyence Biomedical Ltd. updated its common stock purchase agreement with White Lion Capital to add a new intraday share sale option.
Rhea-AI Filing Summary
Psyence Biomedical Ltd. updated its common stock purchase agreement with White Lion Capital to add a new intraday share sale option. During the commitment period, Psyence can issue an Intraday Purchase Notice requiring White Lion to buy common shares up to 5% of the Average Daily Trading Volume per notice.
The purchase price is the lowest traded price during a one-hour valuation window after White Lion’s written acceptance, subject to a floor price set in each notice. White Lion must consent within 15 minutes and settle within two business days. In connection with the amendment, White Lion will pay Psyence a $22,000 legal document preparation fee.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Intraday Purchase Notice financial
Average Daily Trading Volume financial
Commitment Period financial
floor price financial
Business Days financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What change did Psyence Biomedical (PBM) make to its White Lion agreement?
How does the new Intraday Purchase Notice work for Psyence Biomedical (PBM)?
What fee will White Lion pay Psyence Biomedical (PBM) in connection with this amendment?
Does the amendment change Psyence Biomedical’s existing Purchase Agreement with White Lion?
What timing rules apply when Psyence Biomedical (PBM) uses an Intraday Purchase Notice?
AI-generated analysis. How Rhea-AI works. Not financial advice.